Not exact matches
«New
malaria vaccine effective in clinical trial: Researchers achieve protection of up to 100
percent using fully viable
malaria parasites.»
University of Tübingen researchers in collaboration with the biotech company Sanaria Inc. have demonstrated in a clinical trial that a new
vaccine for
malaria called Sanaria ® PfSPZ - CVac has been up to 100
percent effective when assessed at 10 weeks after last dose of
vaccine.
Only one
vaccine has been licensed, and neither it nor any others in development today will be 100
percent effective against
malaria infection, said lead researcher José A. Stoute, associate professor of medicine and microbiology and immunology.